Download Files:
CPI703
SKU
HY-120196-Get quote
Category Reference compound
Tags Cancer, Epigenetic Reader Domain, Epigenetics
Products Details
Product Description
– CPI703, a BRD inhibitor, binds with residues in domain1 of 5DBM complex[1].
Web ID
– HY-120196
Shipping
– Room temperature
Molecular Formula
– C17H22N4O
References
– [1]Srimoyee Ghosh, et al. Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition. J Biol Chem. 2016 Jun 17;291(25):13014-27.|[2]Xue-Song Wang, et al. Theoretical research in structure characteristics of different inhibitors and differences of binding modes with CBP bromodomain. Bioorg Med Chem. 2018 Feb 1;26(3):712-720.
CAS Number
– 1904649-00-8
Molecular Weight
– 298.38
SMILES
– O=C1NC2=CC=CC(C3=CN(C(C)(C)C)N=C3)=C2N[C@H](C)C1
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Epigenetic Reader Domain
Pathway
– Epigenetics
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.